Summit Therapeutics Inc.
SMMT
$18.95
$0.291.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -189.42M | -219.17M | -231.79M | -565.71M | -62.91M |
| Total Depreciation and Amortization | 44.00K | 42.00K | 42.00K | 37.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 68.76M | 108.86M | 130.81M | 477.52M | 7.91M |
| Change in Net Operating Assets | -1.68M | 8.34M | 7.86M | 21.41M | -6.19M |
| Cash from Operations | -122.29M | -101.94M | -93.08M | -66.74M | -61.17M |
| Capital Expenditure | -245.00K | -164.00K | -71.00K | 0.00 | -422.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.00K | -484.99M | 0.00 | 150.81M | 160.53M |
| Cash from Investing | -238.00K | -485.16M | -71.00K | 150.81M | 160.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.80M | 573.82M | 33.81M | 2.22M | 7.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.80M | 573.82M | 33.81M | 2.22M | 7.68M |
| Foreign Exchange rate Adjustments | -19.00K | -19.00K | 22.00K | 61.00K | 38.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.75M | -13.29M | -59.32M | 86.35M | 106.66M |